Alector (ALEC) Retained Earnings (2018 - 2026)
Alector (ALEC) reported Retained Earnings of -$104000.0 for Q1 2026, down 154.45% year-over-year from $191000.0 in Q1 2025, and up 99.99% quarter-over-quarter from -$972.1 million in Q4 2025.
Alector (ALEC) Retained Earnings (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Retained Earnings data on file, last reported at -$104000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$104000.0, down 154.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$104000.0 (down 154.45% YoY), and the FY2025 annual result was -$972.1 million, down 17.24% from the prior year.
- Retained Earnings rose to -$104000.0 in Q1 2026 per ALEC's latest filing, from -$972.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $191000.0 in Q1 2025 and troughed at -$972.1 million in Q4 2025.
- A 5-year average of -$425.5 million and a median of -$491.0 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 119854.63% in 2022, then surged 147.39% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$4.6 million in 2022, then slumped by 15420.83% to -$710.1 million in 2023, then retreated by 16.77% to -$829.1 million in 2024, then fell by 17.24% to -$972.1 million in 2025, then surged by 99.99% to -$104000.0 in 2026.
- Business Quant data shows ALEC's Retained Earnings at -$104000.0 in Q1 2026, -$972.1 million in Q4 2025, and -$934.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -104,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -104,000.00 |
| Dec 31, 2025 | -972.06 Mn |
| Sep 30, 2025 | -934.79 Mn |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | 191,000.00 |
| Dec 31, 2024 | -829.13 Mn |
| Sep 30, 2024 | -827.05 Mn |
| Jun 30, 2024 | -784.83 Mn |
| Mar 31, 2024 | -403,000.00 |
| Dec 31, 2023 | -710.08 Mn |
| Sep 30, 2023 | -668.64 Mn |
| Jun 30, 2023 | -1.39 Mn |
| Mar 31, 2023 | -2.20 Mn |
| Dec 31, 2022 | -4.58 Mn |
| Sep 30, 2022 | -527.26 Mn |
| Jun 30, 2022 | -481.11 Mn |
| Mar 31, 2022 | -490.99 Mn |
| Dec 31, 2021 | -943,000.00 |
| Sep 30, 2021 | -390.77 Mn |
| Jun 30, 2021 | -517.37 Mn |